HOME JOURNALS CONTACT

Journal of Applied Sciences

Year: 2009 | Volume: 9 | Issue: 10 | Page No.: 1936-1942
DOI: 10.3923/jas.2009.1936.1942
Effect of Orexin Infusion into Third Ventricle on the GnRH and LH Secretions in the Prepubertal Rat
H. Khazali and M. Behzadfar

Abstract: The goal of this study was to determine whether orexin affects gonadotropin releasing hormone (GnRH) and Luteinizing Hormone (LH) secretions in the prepubertal male and female rats. Forty prepubertal rats were randomly divided into 4 groups. Animals in group 1 and 2 were male and 3 and 4 were female. Animals in group 1 and 3 received infusions of 1 μg orexin and group 2 and 4 received infusions of 2 μg orexin into their third ventricle. Blood samples were collected from jugular veins, every 30 min from 4 h before the first infusion of orexin until 4 h after the last orexin infusion. Infusions of 1 and 2 μg orexin significantly (p<0.01) decreased the mean plasma concentrations and pulse amplitudes of GnRH and LH in prepubertal female animal. Also, infusions of 1 and 2 μg orexin significantly (p<0.05) decreased the mean plasma concentrations and pulse amplitudes of GnRH and LH in prepubertal male animal, but this decrease were lower in than female prepubertal rat. Infusions of 1 and 2 μg orexin did not change the mean plasma concentrations of FSH in the animal of all groups. Infusions of 1 and 2 μg, orexin significantly (p<0.01) decreased the glucose levels of the prepubertal female animals. The conclusion of this experiment indicated that orexin may negatively affect the GnRH and LH in the prepubertal rats with negative energy balance, but not in those with the positive energy balance.

Fulltext PDF Fulltext HTML

How to cite this article
H. Khazali and M. Behzadfar, 2009. Effect of Orexin Infusion into Third Ventricle on the GnRH and LH Secretions in the Prepubertal Rat. Journal of Applied Sciences, 9: 1936-1942.

Keywords: rat, LH, GnRH and Orexin

INTRODUCTION

Orexin is a 33-amino-acid neuropeptide that is mostly found in hypothalamus (Antunes et al., 2001; Arihara et al., 2000; Backberg et al., 2000). Based on its neuron distributions in the hypothalamus, orexin coexists with many other neurons. For example, orexin neurons are found in high concentrations in hypothalamic areas considered to be important in the regulation of many physiological effects such as food intake, adrenal secretions and reproduction (Antunes et al., 2001; Balasko et al., 1999; Kohsaka et al., 2001). The effect of orexin on reproduction is not very clear. For example, it was shown that orexin decreases or increases GnRH and LH secretions. In humans, it showed that plasma LH concentration is reduced in hypocretin-deficient narcoleptic men, whereas gonadal steroid hormone levels are normal (Kok et al., 2004). The mechanism of this inhibitory effect of decreased orexin is through the decrease in GnRH secretion. This data suggests that orexin increases LH secretions through the GnRH secretions. Moreover, other studies show that intra-cerebroventicular or rostal POA administrations of orexin induces GnRH and LH concentrations in rats (Kohsaka et al., 2001; Pu et al., 1998), whereas administrations of orexin in medial POA and ARC/ME decrease GnRH and LH concentrations in rats (Pu et al., 1998; Russell et al., 2001, 2003). Furthermore, other studies showed that orexins suppressed the pulsatile secretion of LH in ovariectomized female rats (Furuta et al., 2002; Tamura et al., 1999). All of the above studies with the contradictory results were conducted in pubertal human and rats. There are no reports about the orexigenic effect of orexin on the GnRH and LH secretions in prepubertal animals. Therefore, the goal of this experiment was to determine whether orexin affects the GnRH and LH secretions in the prepubertal rats.

MATERIALS AND METHODS

This experiment was conducted in Shahid Beheshti University at Tehran, Iran from April 2006 till November 2008.

Experimental design: Forty rats were randomly divided into 4 groups. Animals in group 1 and 2 were males and animals in group 3 and 4 were females. During the course of the experiment, daily feed was weighed based on body weight and individually given to each rat every morning.

Surgery: All animals were prepared for surgery. Rats were anesthetized throughout the surgery for third ventricle cannulation under stereotaxic methods and jugular vein cannulations. The guide cannula was fixed to the skull with stainless steel screws and dental cement. The external opening to the canal was closed with a stainless steel cap. Orexin (Tabeshyarnoor Co. Ltd.) was dissolved in ethanol and stored at -20 °C as a stock solution (10 mg/500 μL) for no longer than 2 days. Each rat was kept in a single cage for a 5 days recovery period. During the recovery period, cannules were washed by PBS solution to prevent from clotting. Immediately before the experiment it was dissolved in Ringer- Locke solution and a similar solution one without orexin was prepared as the control vehicle. During the experiments, rats were kept in comfortable cages. Rats in group 1 and 3 received 1 μg orexin and in group 2 and 4 received 2 μg orexin into their third ventricles every hour for 4 h. The perfusions flow rate was 5 μL min-1 and the volume of perfusates collected at 30 min intervals was about 10 μL. The tubes for perfusates contained 5 μL of aprotinine (250 IU, a proteolytic enzyme inhibitor) and were kept in an ice bath during sampling. Immediately after filling, they were frozen in liquid nitrogen and stored at -80 °C until assayed for GnRH.

Blood collection: Blood samples were collected from cannules that were put into the jugular veins, every 30 min from 4 h before first infusion of orexin until 4 h after the last orexin infusion following injection with GnRH. Blood samples were kept at 4 °C until centrifugation. A saturated sodium citrate solution (40 μL sodium citrate solution/mL blood) was added to the samples before centrifugation to prevent clotting of plasma during storage. Plasma was stored at -20 °C until assayed for LH.

Hormone assays: Plasma LH were measured by a homologous double-antibody radioimmunoassay (RIA) as described earlier by Pelletier et al. (1982). For LH assay, rat LH (TYN-rLH) and antisera against LH were provided by Tabeshyarnoor Co. (Industrial City of Bu-Ali, Hamadan, Iran). Rat LH (TYN-rLH) was used for iodination. A seven-point standard curve ranging from 0.04 to 10 ng LH was used. An average assay binding of 40% was achieved using an initial 1:20000 dilution of LH antiserum for LH assays. The inter- and intra-assay variations were 6 and 9%, respectively. Plasma GnRH was measured by a homologous double-antibody radioimmunoassay (RIA) as described earlier by Caraty et al. (1997). For GnRH assay, concentrations of GnRH in portal plasma were measured by RIA in duplicate aliquots after methanol extraction using a specific antibody against the C-terminal portion of the molecule as described earlier by Caraty et al. (1997). GnRH assay sensitivity averaged 0.2 pg tube-1 (10 assays) and the inter- and intra-assay variations were 9 and 12%, respectively. The pulse amplitude of GnRH and LH were determined by pulsar program (Merriam and Wachter, 1982).

Statistical analysis: All analysis were conducted using General Linear Model procedures. Data was analyzed using an analysis of variance for a repeated measure design. Mean comparisons were evaluated by least significant difference with single degree of freedom. The number of LH pulses was determined by the PC-PULSAR computer program according to the method of Merriam and Wachter (1982) with the following G parameters: G1 = 3.98, G2 = 2.40, G3 = 1.68, G4 = 1.24 and G5 = 0.93.

RESULTS

GnRH and LH: Infusions of 1 and 2 μg orexin significantly (p<0.01) decreased the mean plasma concentrations and pulse amplitudes of GnRH and LH in prepubertal female animal. Also, infusions of 1 and 2 μg orexin significantly (p<0.05) decreased the mean plasma concentrations and pulse amplitudes of GnRH and LH in prepubertal male animal, but this decrease were lower in than female prepubertal rat (Fig. 1, 2).

Mean plasma LH levels of the animals in group 3 and 4 were about 2.8, 1.4, 2.9 and 2.8, 1.5, 3 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 1). Also, mean pulse amplitudes of LH of the animals in group 3 and 4 were about 0.6, 0.7, 0. 7 and 0.7, 0.5, 0.7 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 1). Mean portal plasma GnRH concentrations levels of the animals in group 3 and 4 were about 95, 77, 102 and 99, 75, 102 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 2). Mean pulse amplitudes of GnRH of the animals in group 3 and 4 were about 29, 22, 32 and 32. 21, 33 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 2). Infusions of 1 and 2 μg orexin into third ventricle decreased mean plasma concentrations and pulse amplitudes of GnRH and LH of the animals in groups 1 and 2. Mean plasma LH levels of the animals in group 1 and 2 were about 4.1, 31, 4 and 4, 3, 4 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 1). Also, mean pulse amplitudes of LH of the animals in group 1 and 2 were about 0.97, 0.75, 0. 8 and 0.95. 0.75 and 0.86 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 1).

Fig. 1:
(a) Mean pulse amplitude and (b) mean plasma concentrations of LH of the animals in the different groups of 1 (NE and 1 μg orexin), 2 (NE and 2 μg orexin), 3 (LE and 1 μg orexin) and 4 (LE and 1 μg orexin) and before, during and after infusions of orexin (NE: Normal Energy; LE: Low Energy). Treatments with different letter(s) are different at p<0.01

Fig. 2:
(a) Mean pulse amplitude and (b) mean plasma concentrations of GnRH of the animals in the different groups of 1 (NE and 1 μg orexin), 2 (NE and 2 μg orexin), 3 (LE and 1 μg orexin) and 4 (LE and 1 μg orexin) and before, during and after infusions of orexin (NE: Normal Energy; LE: Low Energy). Treatments with different letter(s) are different at p<0.01

Mean portal plasma GnRH concentrations levels of the animals in group 1 and 2 were about 105, 82, 102 and 102, 81, 104 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 2). Also, mean pulse amplitudes of GnRH of the animals in group 1 and 2 were 40, 30, 39 and 38. 31, 40 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 2). Figure 4 and 5 show the changes of GnRH and LH pulsatile secretions of prepubertal female rats No. 171 and 175 as a samples. Higher dosage of orexin infusion caused more decrease in mean concentrations of GnRH and LH in rat No. 171, whereas these effects were less observed in prepubertal male rats (Fig. 6, 7).

FSH: Infusions of 1 and 2 μg orexin did not change the mean plasma concentrations of FSH in the animal of all groups. Mean plasma FSH levels of the animals in group 1-4 were about 4.1, 4.0, 4 and 4, 3.4, 3.9 ng mL-1 before, during and after infusion of orexin, respectively (Fig. 3).

Glucose: Orexin did not change the mean plasma glucose concentrations of the animals in group 1 and 2 that were pubertal males. Mean plasma glucose concentrations of the animals in group 1 and 2 were 47, 51, 42 and 52, 48, 47 mg dL-1 before, during and after infusion of orexin, respectively (Fig. 3). Infusions of 1 and 2 μg orexin significantly (p<0.01) decreased the glucose levels of the prepubertal female nimals. Mean plasma glucose concentrations of the animals in groups 3 and 4 were 48, 16, 22 and 52, 14, 24 mg dL-1 before, during and after infusion of orexin, respectively (Fig. 3).

Fig. 3:
(a) Mean plasma concentrations of (a) FSH and (b) glucose of the animals in the different groups of 1 (NE and 1 μg orexin), 2 (NE and 2 μg orexin), 3 (LE and 1 μg orexin) and 4 (LE and 1 μg orexin) and before, during and after infusions of orexin (NE: Normal energy; LE: Low energy). Treatments with different letter(s) are different at p<0.01

Fig. 4: (a) Mean plasma concentrations and (b) pulse amplitude of GnRH and LH of the prepubertal female rat received 1 μg orexin

Fig. 5: (a) Mean plasma concentrations and (b) pulse amplitude of GnRH and LH of the prepubertal female rat received 2 μg orexin

Fig. 6: (a) Mean plasma concentrations and (b) pulse amplitude of GnRH and LH of the prepubertal male rat received 1 μg orexin

Fig. 7: (a) Mean plasma concentrations and (b) pulse amplitude of GnRH and LH of the prepubertal male rat received 2 μg orexin

Body weight: Restricted diet for 10 days significantly (p<0.01) decreased the mean body weight of the animals. This was similar to the earlier finding reported that negative energy balance decreases body weight (Towhidi et al., 2007).

DISCUSSION

The results of this study demonstrate that 1 or 2 μg of administration of orexin directly into the third ventricle significantly (p<0.01) decreased the mean plasma concentrations and pulse amplitudes of GnRH and LH in the pubertal male and female rats. Present results are different from earlier studies that showed a stimulatory effect of orexin on the secretory activity of the GnRH/LH axis in humans and rats (Kok et al., 2004; Kohsaka et al., 2001; Pu et al., 1998). This may be due to the fact that increase in orexin receptors in the cell body of GnRH neurons are observed in pubertal animal that may cause in the increasing of the secretion of GnRH and LH in the subjects. Contrastly, in this study the animals of the all groups are prepubertal and since the orexin receptors in the cell body of GnRH neurons are not formed, therefore decrease in the secretion of GnRH and LH upon infusion of orexin may happen throug h the ventromedial hypothalamic area and lateral hypothalamic area (Date et al., 1999; Dun and Chang, 2000; Ehmke and Jus, 2003). Therefore, orexin activates the lateral hypothalamic neurons that indirectly inactivate the GnRH secreting neurons (Al-Barazanji et al., 2001; Hagan et al., 1999; Horvath et al., 1999; Jones et al., 2001). The other mechanism is the inhibitory effect of orexin on the GnRH secreting neurons at the ME, as it is suggested that a subset of GnRH neurons responsible for episodic GnRH, and hence LH secretion, is located within the MBH (Boukhliq et al., 1999). Moreover, much of the GnRH axons have terminals in the ME, a structure located on the ventral part of the MBH.

The FSH result of this study also is first to show that orexin infusion did not change the plasma FSH level in the animals of all groups, which is an indication of negative energy balance, but not in the rats fed NE diet with normal glucose concentrations. The result of this study is different with the earlier finding of Kok et al. (2004) that showed plasma FSH level of hypocretin-deficient narcoleptic men is as normal as normal men. This may be due to restricted dietary intake that caused severe body weight loss.

The result of this study regarding the effect of the orexin on glucose concentration is similar to the earlier findings of Quedraogo et al. (2003) and Willie et al. (2002) that indicated a negative correlation between orexin and mean plasma level of glucose in vitro. This may be due to decreased level of glucagon (Meghan and Samsom, 2003) along with increase in insulin concentrations (Megahan and Samson, 2003; Nowak et al., 2005). The result of this study showed that fasted animals are more susceptible to orexin physiological effect.

CONCLUSION

The results of this study indicate that orexin decrease GnRH and LH secretions in prepubetal male and female rats.

ACKNOWLEDGMENTS

We wish to thank Fariba Mahmoudi for assistance with the radioimmunoassay. This study was supported in part by Grant No. 60016011095 from the Shahid Beheshti University.

REFERENCES

  • Al-Barazanji, K.A., S. Wilson, J. Baker, D.S. Jessop and M.S. Harbuz, 2001. Central orexin-A activates hypothalamic-pituitaryadrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol., 13: 421-424.
    Direct Link    


  • Antunes, V.R., G. Brailoiu, E.H. Kwok, P. Scruggs and N.J. Dun, 2001. Orexins hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am. J. Physiol. Regul. Integr. Comput. Physiol., 281: 1801-1807.
    Direct Link    


  • Arihara, Z., K. Takahashi, O. Murakami, K. Totsune and M. Sone et al., 2000. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides, 21: 565-570.
    Direct Link    


  • Backberg, M., G. Hervieu, S. Wilson and B. Meister, 2002. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: Focus on orexin targets involved in control of food and water intake. Eur. J. Neurosci., 15: 315-328.
    PubMed    Direct Link    


  • Balasko, M., Z. Szelenyi and M. Szekely, 1999. Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol. Hung., 86: 219-222.
    PubMed    


  • Boukhliq, R., R.L. Goodman, S.J. Berriman, B. Adrian and M.N. Lehman, 1999. Subset of gonadotropin-releasing hormone neurons in the ovine medial basal hypothalamus is activated during increased pulsatile luteinizing hormone secretion. Endocrinology, 12: 5929-5936.
    Direct Link    


  • Caraty, A., D.W. Miller, B. Delaleu and G.B. Martin, 1997. Stimulation of LH secretion in sheep b central administration of corticotrophin-releasing hormone. J. Reprod. Fertil., 111: 249-257.
    Direct Link    


  • Date, Y., Y. Ueta, H. Yamashita, H. Yamaguchi and S. Matsukura et al., 1999. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA., 96: 748-753.
    Direct Link    


  • Dun, N.J. and K.J. Chang, 2000. Orexin A-like immunoreactivity in the rat brain. Neurosci. Lett., 260: 161-164.


  • Ehmke, H. and A. Just, 2003. The orexins: linking circulatory control with behavior. Am. J. Physiol. Regul. Integr. Comp. Physiol., 285: 519-521.
    Direct Link    


  • Furuta, M., T. Funabashi and F. Kimura, 2002. Suppressive action of orexin A on pulsatile luteinizing hormone secretion is potentiated by a low dose of oestrogen in ovariectomised rats. Neuroendocrinology, 75: 151-157.
    Direct Link    


  • Hagan, J.J., R.A. Leslie, S. Patel, M.L. Evans and T.A. Wattam et al., 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci., 96: 10911-10916.
    Direct Link    


  • Horvath, T.L., C. Peyron, S. Diano, A. Ivanov, G. Aston-Jones, T.S. Kilduff and A.N. Van-Den Pol, 1999. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol., 415: 145-159.
    PubMed    


  • Jones, D.N., J. Gartlon and F. Parker, 2001. Effects of centrally administered orexin-B and orexin-A: A role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology, 153: 210-218.
    Direct Link    


  • Kohsaka, A., H. Watanobe, Y. Kakizaki, T. Suda and H.B. Schio, 2001. A significant participation of orexin-A, a potent orexigenic peptide, in the preovulatory luteinizing hormone and prolactin surges in the rat. Brain Res., 898: 166-170.
    Direct Link    


  • Kok, S.W., S. Roelfsema, G.L. Overeem, M. Lammers, A. Frolich, E. Meinders and M. Pijl, 2004. Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am. J. Physiol Endocrinol. Metab., 287: 630-636.
    Direct Link    


  • Meghan, M. and K. Samson, 2003. The other side of the orexins: Endocrine and metabolic actions. Am. J. Physiol. Endocrinol. Meta., 284: 13-17.
    Direct Link    


  • Merriam, G.R. and K.W. Wachter, 1982. Algorithms for the study of episodic hormone secretion. Am. J. Physiol., 243: 310-318.
    Direct Link    


  • Nowak, K.W., M.Z. Strowski, M.M. Switonska, P. Kaczmarek and V. Singh et al., 2005. Evidence that orexins A and B stimulate insulin secretion from rat pancreatic islets via both receptor subtypes. Int. J. Mol. Meta., 15: 969-972.
    Direct Link    


  • Pelletier, J., D.H. Garnier, M.M. De Reviers, M. Terqui and R.O. Ortavant, 1982. Seasonal variation in LH and testosterone release in the rams of two breeds. J. Reprod. Fertil., 64: 341-346.
    Direct Link    


  • Pu, S., M.R. Jain, P.S. Kalra and S.P. Kalra, 1998. Regulatory peptides. J. Biol. Chem., 276: 34631-34636.


  • Quedraogo, R., R. Naslaud and A. Kirshgesner, 2003. Glucose regulate the release of orexin from the pancreas. Diabetes, 52: 111-117.
    Direct Link    


  • Russell, S.H., C.J. Small, A.R. Kennedy, S.A. Stanley and A. Seth et al., 2003. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology, 142: 5294-5302.
    Direct Link    


  • Russell, S.H., C.J. Small and C.L. Dakin, 2001. The central effects of orexin-A in the hypothalamic pituitary adrenal axis in vivo and in vitro in male rats. J. Neuroendocrinol., 13: 561-566.
    Direct Link    


  • Tamura, T., M. Irahara, M. Tezuka, M. Kiyokawa and T. Aono, 1999. Orexins, orexigenic hypothalamic neuropeptides, suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats. Biochem. Biophys. Res. Commun., 264: 759-762.
    Direct Link    


  • Towhidi, A., H. Khazali and M. Zhandi, 2007. Leptin Is a metabolic signal for GnRH-LH/FSH axis in feed-restricted ewes. Asian-Aust. J. Anim. Sci., 20: 1039-1048.
    Direct Link    


  • Willie, J.T., T. Sakurai, J. Hara, H. Takahira, H.K. Gershenfeld and M. Yanagisawa, 2002. Ectopic expression of orexin transgene alters body weight and energy metabolism in mice. Society for Neuroscience Meeting, Orlando, FL abstract 320.

  • © Science Alert. All Rights Reserved